Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy. GJSFR 2024, 24 (G1), 1-3. https://doi.org/10.34257/GJSFRGVOL24IS1PG1.